1. Nâacetylcysteine reduces lipopolysaccharideâsensitized hypoxicâischemic brain injury.
- Author
-
Xiaoyang Wang, Pernilla Svedin, Chunxia Nie, Risto Lapatto, Changlian Zhu, Malin Gustavsson, Mats Sandberg, JanâOlof Karlsson, Roberto Romero, Henrik Hagberg, and Carina Mallard
- Subjects
- *
BRAIN injuries , *ISCHEMIA , *CEREBRAL anoxia , *CELL death - Abstract
Maternal inflammation/infection alone or in combination with birth asphyxia increases the risk for perinatal brain injury. Free radicals are implicated as major mediators of inflammation and hypoxiaâischemia (HI)âinduced perinatal brain injury. This study evaluated the neuroprotective efficacy of a scavenging agent, Nâacetylcysteine (NAC), in a clinically relevant model.Lipopolysaccharide (LPS)âsensitized HI brain injury was induced in 8âdayâold neonatal rats. NAC was administered in multiple doses, and brain injury was evaluated at 7 days after HI.NAC (200mg/kg) provided marked neuroprotection with up to 78% reduction of brain injury in the preꚋâHI treatment group and 41% in the early (0 hour) postâHI treatment group, which was much more pronounced protection than another free radical scavenger, melatonin. Protection by NAC was associated with the following factors: (1) reduced isoprostane activation and nitrotyrosine formation; (2) increased levels of the antioxidants glutathione, thioredoxinâ2, and (3) inhibition of caspaseâ3, calpain, and caspaseâ1 activation.NAC provides substantial neuroprotection against brain injury in a model that combines infection/inflammation and HI. Protection by NAC was associated with improvement of the redox state and inhibition of apoptosis, suggesting that these events play critical roles in the development of lipopolysaccharideâsensitized HI brain injury. Ann Neurol 2007 [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF